“After oil prices plummeted, I went on record saying I thought they’d be back above $70 per barrel by the end of 2015. The year isn’t over yet, but my prediction isn’t looking good.” That’s what oil tycoon T. Boone Pickens just told the CNBC audience, still unwilling to abandon his call for $70 oil.…
Details“We’re deeply sorry if any fans are having difficulty purchasing today, we’re doing everything we can do make sure more stock arrives very shortly.” That’s the note Alex Verrey, the PR executive for Mad Catz just issued to fans because of issues of short supply of the very popular Rock Star 4. Mad Catz partnered…
DetailsThe biggest investment story of 2016 is just starting to come into focus. Few analysts have really realized the full impact of it yet. Most never will. One person, however, is all over it. That’s Donald Trump.
DetailsThe biotech-related tweet heard ‘round the world has been priced in. We have to remember that the underlying catalysts are still in place for a multi-year boom in biotech. More than 80 million baby boomers are retiring over the next 20 years. Another 32 million Americans have coverage they never had. We’re seeing advancements in…
Details“How was Italy?” My friend Freddy who just returned from a trip to show his kids his homeland and I expected any number of superlative. Captivating…enthralling…breathtaking…All would do. His reply? Expensive.
DetailsIt hasn’t been this bad in 200 years, blare the headlines. Twenty million Americans are on flood watch. Another 65 million could be impacted. Parts of the eastern shore had up to 12 inches of rain. Others expect up to 15 inches.
DetailsOver the last few days, Sterne Agee analysts upgraded JC Penney (JCP – NYSE) from a neutral rating to a buy rating with a price target of $13. After spending time with the JCP’s new CEO, the firm became a bit more confident in its turnaround plan, as the new guy focuses on previous core…
DetailsWe last saw this disturbing trend 25 years ago… Back in 1990, Wall Street firms lost as much as $500 million, stark evidence of the economic disaster that gripped the markets. A sharp decline in profitability had been widely expected for months. Tensions in the Middle East slowed trading volume, forcing many investors out of…
DetailsThe last flu season was bad, as we noted here. One of the worst in history… It was nothing short of an epidemic. Last year, Texas reported more than a dozen flu-related deaths.
DetailsYou haven’t missed the biotech boom yet. It’s up 228% from October 2011 lows and still likely to hit new highs, despite news of a 91-character tweet. Even if you’ve missed the run so far… You’re not out of luck. In fact, the opportunities we’re spotting are tough to ignore. A $35 Billion Opportunity Over…
DetailsThe last flu season was bad. One of the worst in history. Flu-related hospitalizations were 30% higher year over year and more than double the prior year. At the end, 141 children died. The flu vaccine was 23% effective, potentially exposing 60 million Americans to the devastating effects of the flu. The Centers for Disease…
DetailsWhen a heavyweight has a big problem, it’s always natural for investors to begin thinking about buying in… After all, when the blood is running in the streets – even if it’s your own – buy. At least, that’s what Baron Rothschild has said.
Details
